379 related articles for article (PubMed ID: 25459689)
1. Prenatal arsenic exposure alters the programming of the glucocorticoid signaling system during embryonic development.
Caldwell KE; Labrecque MT; Solomon BR; Ali A; Allan AM
Neurotoxicol Teratol; 2015; 47():66-79. PubMed ID: 25459689
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
Thompson A; Han VK; Yang K
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
[TBL] [Abstract][Full Text] [Related]
3. Arsenic exposure during embryonic development alters the expression of the long noncoding RNA growth arrest specific-5 (Gas5) in a sex-dependent manner.
Caldwell KK; Hafez A; Solomon E; Cunningham M; Allan AM
Neurotoxicol Teratol; 2018; 66():102-112. PubMed ID: 29132937
[TBL] [Abstract][Full Text] [Related]
4. Spatial and temporal patterns of expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 messenger RNA and glucocorticoid receptor protein in the murine placenta and uterus during late pregnancy.
Thompson A; Han VK; Yang K
Biol Reprod; 2002 Dec; 67(6):1708-18. PubMed ID: 12444044
[TBL] [Abstract][Full Text] [Related]
5. Prenatal alcohol exposure and prenatal stress differentially alter glucocorticoid signaling in the placenta and fetal brain.
Lan N; Chiu MP; Ellis L; Weinberg J
Neuroscience; 2017 Feb; 342():167-179. PubMed ID: 26342748
[TBL] [Abstract][Full Text] [Related]
6. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development.
Speirs HJ; Seckl JR; Brown RW
J Endocrinol; 2004 Apr; 181(1):105-16. PubMed ID: 15072571
[TBL] [Abstract][Full Text] [Related]
7. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice.
Wyrwoll CS; Seckl JR; Holmes MC
Endocrinology; 2009 Mar; 150(3):1287-93. PubMed ID: 18845627
[TBL] [Abstract][Full Text] [Related]
8. Sex-Dependent effects of developmental arsenic exposure on methylation capacity and methylation regulation of the glucocorticoid receptor system in the embryonic mouse brain.
Allan AM; Hafez AK; Labrecque MT; Solomon ER; Shaikh MN; Zheng X; Ali A
Toxicol Rep; 2015 Oct; 2():1376-1390. PubMed ID: 26855884
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
Yu P; Zhou J; Ge C; Fang M; Zhang Y; Wang H
Sci Total Environ; 2022 Jun; 827():154396. PubMed ID: 35259391
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells.
Julan L; Guan H; van Beek JP; Yang K
Endocrinology; 2005 Mar; 146(3):1482-90. PubMed ID: 15591138
[TBL] [Abstract][Full Text] [Related]
11. Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydrogenase type 2 expression and the adult metabolic disorders in mice.
Ni L; Pan Y; Tang C; Xiong W; Wu X; Zou C
PLoS One; 2018; 13(9):e0203802. PubMed ID: 30212527
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.
Wyrwoll CS; Noble J; Thomson A; Tesic D; Miller MR; Rog-Zielinska EA; Moran CM; Seckl JR; Chapman KE; Holmes MC
Proc Natl Acad Sci U S A; 2016 May; 113(22):6265-70. PubMed ID: 27185937
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
Waddell BJ; Benediktsson R; Brown RW; Seckl JR
Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929
[TBL] [Abstract][Full Text] [Related]
14. nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2.
Zhou J; Liu F; Yu L; Xu D; Li B; Zhang G; Huang W; Li L; Zhang Y; Zhang W; Wang H
Toxicol Appl Pharmacol; 2018 Apr; 344():1-12. PubMed ID: 29486207
[TBL] [Abstract][Full Text] [Related]
15. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
Cottrell EC; Holmes MC; Livingstone DE; Kenyon CJ; Seckl JR
FASEB J; 2012 May; 26(5):1866-74. PubMed ID: 22321728
[TBL] [Abstract][Full Text] [Related]
16. Foetal and placental 11β-HSD2: a hub for developmental programming.
Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
[TBL] [Abstract][Full Text] [Related]
17. cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expression.
Yu L; Zhou J; Zhang G; Huang W; Pei L; Lv F; Zhang Y; Zhang W; Wang H
Toxicol Appl Pharmacol; 2018 Aug; 352():77-86. PubMed ID: 29802914
[TBL] [Abstract][Full Text] [Related]
18. Role of human chorionic gonadotropin in maintaining 11beta-hydroxysteroid dehydrogenase type 2 expression in human placental syncytiotrophoblasts.
Ni XT; Duan T; Yang Z; Guo CM; Li JN; Sun K
Placenta; 2009 Dec; 30(12):1023-8. PubMed ID: 19880179
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids stimulate the expression of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells.
van Beek JP; Guan H; Julan L; Yang K
J Clin Endocrinol Metab; 2004 Nov; 89(11):5614-21. PubMed ID: 15531519
[TBL] [Abstract][Full Text] [Related]
20. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development.
Brown RW; Diaz R; Robson AC; Kotelevtsev YV; Mullins JJ; Kaufman MH; Seckl JR
Endocrinology; 1996 Feb; 137(2):794-7. PubMed ID: 8593833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
